We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Soft Bioelectronic Sensor Implant Can Monitor Signals in the Developing Brain

soft, conformable implant that measures neurological signals in patients’ developing brains, seen here on the wing of a butterfly.
Credit: Duncan Wisniewski / UC Irvine.
Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: 2 minutes

Researchers at the University of California, Irvine and New York’s Columbia University have embedded transistors in a soft, conformable material to create a biocompatible sensor implant that monitors neurological functions through successive phases of a patient’s development.


In a paper published recently in Nature Communications, the UC Irvine scientists describe their construction of complementary, internal, ion-gated, organic electrochemical transistors that are more amenable chemically, biologically and electronically to living tissues than rigid, silicon-based technologies. The medical device based on these transistors can function in sensitive parts of the body and conform to organ structures even as they grow.


“Advanced electronics have been in development for several decades now, so there is a large repository of available circuit designs. The problem is that most of these transistor and amplifier technologies are not compatible with our physiology,” said co-author Dion Khodagholy, Henry Samueli Faculty Excellence Professor in UC Irvine’s Department of Electrical Engineering and Computer Science. “For our innovation, we used organic polymer materials that are inherently closer to us biologically, and we designed it to interact with ions, because the language of the brain and body is ionic, not electronic.”

Want more breaking news?

Subscribe to Technology Networks’ daily newsletter, delivering breaking science news straight to your inbox every day.

Subscribe for FREE

In standard bioelectronics, complementary transistors have been composed of different materials to account for different polarities of signals, which, in addition to being unyielding and cumbersome, present the risk of toxicity when implanted in sensitive areas. The team of researchers from UC Irvine and Columbia University worked around this problem by creating its transistors in an asymmetric fashion that enables them to be operated using a single, biocompatible material.


“A transistor is like a simple valve that controls the flow of current. In our transistors, the physical process that controls this modulation is governed by the electrochemical doping and de-doping of the channel,” said first author Duncan Wisniewski, Columbia University Ph.D. candidate during the project who is now a visiting scholar in the UC Irvine Department of Electrical Engineering and Computer Science. “By designing devices with asymmetrical contacts, we can control the doping location in the channel and switch the focus from negative potential to positive potential. This design approach allows us to make a complementary device using a single material.”


He added that arraying transistors into a smaller, single-polymer material greatly simplifies the fabrication process, enabling large-scale manufacturing and opportunities to expand the technology beyond the original neurological application to almost any biopotential processes.


Khodagholy, who heads the UC Irvine Translational Neuroelectronics Laboratory, which recently moved to Irvine from Columbia University, said that his team’s work has the added benefit of scalability: “You can make different device sizes and still maintain this complementarity, and you can even change the material, which makes this innovation applicable in multiple situations.”

Another advantage highlighted in the Nature Communications paper is that the device can be implanted in a developing animal and withstand transitions in tissue structures as the organism grows, something that is not possible with hard, silicon-based implants.


“This characteristic will make the device particularly useful in pediatric applications,” said co-author Jennifer Gelinas, UC Irvine associate professor of anatomy and neurobiology as well as pediatrics, who’s also a physician at Children’s Hospital of Orange County.


“We demonstrated our ability to create robust complementary, integrated circuits that are capable of high-quality acquisition and processing of biological signals,” Khodagholy said. Complementary, internal, ion-gated, organic electrochemical transistors “will substantially broaden the application of bioelectronics to devices that have traditionally relied on bulky, nonbiocompatible components.”


Reference: Wisniewski DJ, Ma L, Rauhala OJ, et al. Spatial control of doping in conducting polymers enables complementary, conformable, implantable internal ion-gated organic electrochemical transistors. Nat Commun. 2025;16(1):517. doi: 10.1038/s41467-024-55284-w


This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source. Our press release publishing policy can be accessed here.